seres therapeutics stock price target
On the other hand Seres Therapeutics target price is what analysts think the stock is worth or could sell for. Oppenheimer Adjusts Seres Therapeutics Price Target to 13 From 16 Maintains Outperfo.
Seres Therapeutics Nasdaq Mcrb Quotes And News Summary Benzinga
2500 Spread Highest target.
. The current price of Seres Therapeutics is the price at which Seres Therapeutics is currently trading. Seres Therapeutics NASDAQMCRB is set to give its latest quarterly earnings report on Wednesday 2022-08-03. 1500 Spread Average Target.
2 days agoSeres Therapeutics NASDAQMCRB - Get Rating had its target price lowered by equities research analysts at Chardan Capital from 1600 to 1200 in a note issued to investors on Thursday The Fly reportsChardan Capitals price objective suggests a potential upside of 15370 from the stocks previous close. Given the current short-term trend the stock is expected to fall -1386 during the next 3 months. Last Close Price.
Seres Therapeutics Inc. Webull Financial LLC is a member of SIPC which protects securities customers of its. The 14 analysts offering price forecasts for Seres Therapeutics have a median target of 2786 with a high estimate of 4600 and a low estimate of 700.
Posted by MarketBeat News on Jul 31st 2022. The information contained herein is. The forecasts range from a low of 700 to a high of.
The average Seres Therapeutics price target of 28 implies 2522 upside potential to current levels. High Price Target. 700 Spread Lowest Target.
NASDAQMCRB Price Target at 1600. According to 1 Wall Street analyst that have issued a 1 year MCRB price target the average MCRB. Shares are logging -5825 during the 52-week period from high price and 9520 higher than the lowest price point for the same timeframe.
MT Newswires 08042022 0544. NASDAQMCRBs beta value is currently sitting at 317 while the Average True Range indicator is currently displaying 031. Based on short-term price targets offered by five analysts the average price target for Seres Therapeutics comes to 1480.
Seres Therapeutics Target Price Projection Seres Therapeutics current and average target prices are 411 and 2283 respectively. MCRB updated stock price target summary. How to buy Seres Therapeutics stock online.
ET by Tomi Kilgore Seres Therapeutics downgraded to neutral from buy at BofA Merrill Lynch. Securities Investor Protection Corporation The New York Stock Exchange NASDAQ and Cboe EDGX Exchange Inc. Median 1300.
With analysts defining 400-2500 as the low and high price targets we arrive at a consensus price target of 1400 for the trailing 12-month period. Other analysts have also recently issued research. The consensus price target rose 71 to US1500 with the analysts encouraged by the higher revenue and lower forecast losses for this year.
Seres Therapeutics Inc. Seres Therapeutics stock price target cut to 13 from 44 at BofA Merrill Lynch Aug. The Seres Therapeutics stock price is 403 USD today.
Brokerages Set Seres Therapeutics Inc. Presently Seres Therapeutics Inc. Stock Price Forecast The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 1300 with a high estimate of 2500 and a low estimate of 400.
NASDAQMCRB Receives 1600 Consensus Price Target from Brokerages Posted by admin on Jul 31st 2022 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits. --Oppenheimer Adjusts Seres Therapeutics Price Target to 12 From 13 Maintains Outperform Rating. 488 Average target price.
Seres Therapeutics Inc. You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm such as TD Ameritrade or tastyworks. 1 2016 at 1111 am.
Stock Price Target MCRB. Analyst ratings historical stock prices earnings estimates actuals. The stocks price range for the 52-week period managed to maintain the performance between 250 and 1169.
Broker Revenue Forecasts For Seres Therapeutics Inc Nasdaq Mcrb Are Surging Higher Nasdaq
Mcrb Stock Price And Chart Nasdaq Mcrb Tradingview
Best Biotech Stocks Which Companies Have Growth Potential
The Biotech Sector Nears An Inflection Point Analysts Offer 3 Stocks To Consider Nasdaq
Seres Therapeutics Mcrb Stock Price News Info The Motley Fool
Mcrb Seres Therapeutics Inc Cnnmoney Com
Is Seres Therapeutics Still A Buy After Disappointing Ser 287 Topline Results
Seres Therapeutics Stock Here We Go Again Nasdaq Mcrb Seeking Alpha
3 Biotech Stocks Under 5 With 100 Plus Upside Potential
Shareholders In Seres Therapeutics Nasdaq Mcrb Have Lost 75 As Stock Drops 8 6 This Past Week
Dow Gains More Than 250 Points As Bond Yields Fall Traders Shake Off Target Profit Warning
Why Did Seres Therapeutics Rise 14 4 Last Week
Seres Therapeutics Inc Nasdaq Mcrb Analysts Just Slashed This Year S Revenue Estimates By 59
Seres Therapeutics Reiterating Buy Rating With Price Target Increased To 15 Nasdaq Mcrb Seeking Alpha
Seres Therapeutics Nasdaqgs Mcrb Share Price News Analysis Simply Wall St
Seres Therapeutics Armed With New Safety Data Eyes First Fda Approval For A Microbiome Drug Fierce Biotech
Seres Therapeutics Up By 390 In A Day This Analyst Sees More Upside In The Cards
Best Biotech Stocks Which Companies Have Growth Potential
Mcrb Seres Therapeutics Inc Stock Overview U S Nasdaq Barron S